MIR208A (microRNA 208a) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: MIR208A (microRNA 208a) Homo sapiens
Analyze
Symbol: MIR208A
Name: microRNA 208a
RGD ID: 1346072
HGNC Page HGNC:31585
Description: Enables mRNA 3'-UTR binding activity and mRNA base-pairing translational repressor activity. Involved in several processes, including miRNA-mediated gene silencing by inhibition of translation; negative regulation of calcium ion transmembrane transport; and positive regulation of cell migration. Located in extracellular exosome. Biomarker of coronary artery disease.
Type: ncrna (Ensembl: miRNA)
RefSeq Status: PROVISIONAL
Previously known as: hsa-mir-208a; MIR208; MIRN208; MIRN208A; miRNA208
RGD Orthologs
Mouse
Rat
Dog
Alliance Orthologs
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381423,388,596 - 23,388,666 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1423,388,596 - 23,388,666 (-)EnsemblGRCh38hg38GRCh38
GRCh371423,857,805 - 23,857,875 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 361422,927,644 - 22,927,714 (-)NCBINCBI36Build 36hg18NCBI36
Celera143,720,516 - 3,720,586 (-)NCBICelera
Cytogenetic Map14q11.2NCBI
HuRef143,974,223 - 3,974,293 (-)NCBIHuRef
CHM1_11423,856,477 - 23,856,547 (-)NCBICHM1_1
T2T-CHM13v2.01417,589,612 - 17,589,682 (-)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
2,5-hexanedione  (ISO)
Allylamine  (ISO)
cadmium atom  (ISO)
cadmium dichloride  (ISO)
Diosbulbin B  (ISO)
isoprenaline  (ISO)
paraquat  (EXP)
radon atom  (EXP)
radon(0)  (EXP)
resveratrol  (EXP,ISO)
triclosan  (EXP)
zinc atom  (EXP,ISO)
zinc(0)  (EXP,ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process

Cellular Component

Molecular Function

Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
References

References - curated
# Reference Title Reference Citation
1. MiR-320a contributes to atherogenesis by augmenting multiple risk factors and down-regulating SRF. Chen C, etal., J Cell Mol Med. 2015 May;19(5):970-85. doi: 10.1111/jcmm.12483. Epub 2015 Feb 27.
2. Cyclic stretching boosts microRNA-499 to regulate Bcl-2 via microRNA-208a in atrial fibroblasts. Chua SK, etal., J Cell Mol Med. 2021 Mar;25(6):3113-3123. doi: 10.1111/jcmm.16373. Epub 2021 Feb 18.
3. Trbp regulates heart function through microRNA-mediated Sox6 repression. Ding J, etal., Nat Genet. 2015 Jul;47(7):776-83. doi: 10.1038/ng.3324. Epub 2015 Jun 1.
4. MicroRNA-208a Potentiates Angiotensin II-triggered Cardiac Myoblasts Apoptosis via Inhibiting Nemo-like Kinase (NLK). Huang Y, etal., Curr Pharm Des. 2016;22(31):4868-4875. doi: 10.2174/1381612822666160210143047.
5. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
6. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
7. MicroRNA-208a: a Good Diagnostic Marker and a Predictor of no-Reflow in STEMI Patients Undergoing Primary Percutaneuos Coronary Intervention. Salama AM, etal., J Cardiovasc Transl Res. 2020 Dec;13(6):988-995. doi: 10.1007/s12265-020-10020-9. Epub 2020 May 26.
8. MicroRNA-208a Dysregulates Apoptosis Genes Expression and Promotes Cardiomyocyte Apoptosis during Ischemia and Its Silencing Improves Cardiac Function after Myocardial Infarction. Tony H, etal., Mediators Inflamm. 2015;2015:479123. doi: 10.1155/2015/479123. Epub 2015 Nov 25.
Additional References at PubMed
PMID:12554859   PMID:16381832   PMID:17379774   PMID:19726871   PMID:20029200   PMID:20190813   PMID:20447577   PMID:22713968   PMID:23034410   PMID:23121236   PMID:24253456   PMID:24461990  
PMID:24604208   PMID:25023649   PMID:25125495   PMID:25198728   PMID:25840809   PMID:26169693   PMID:26526403   PMID:26528525   PMID:26754670   PMID:26974694   PMID:27545043   PMID:27634902  
PMID:28159509   PMID:28481393   PMID:28554251   PMID:29886152   PMID:30696455   PMID:31104928   PMID:31432113   PMID:31637737   PMID:31732917   PMID:31885748   PMID:32151564   PMID:32207065  
PMID:32711895   PMID:33533026   PMID:34195287   PMID:34686514   PMID:34831374   PMID:35607440   PMID:38664873  


Genomics

Comparative Map Data
MIR208A
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381423,388,596 - 23,388,666 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1423,388,596 - 23,388,666 (-)EnsemblGRCh38hg38GRCh38
GRCh371423,857,805 - 23,857,875 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 361422,927,644 - 22,927,714 (-)NCBINCBI36Build 36hg18NCBI36
Celera143,720,516 - 3,720,586 (-)NCBICelera
Cytogenetic Map14q11.2NCBI
HuRef143,974,223 - 3,974,293 (-)NCBIHuRef
CHM1_11423,856,477 - 23,856,547 (-)NCBICHM1_1
T2T-CHM13v2.01417,589,612 - 17,589,682 (-)NCBIT2T-CHM13v2.0
Mir208a
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391455,186,517 - 55,186,599 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1455,186,517 - 55,186,599 (-)EnsemblGRCm39 Ensembl
GRCm381454,949,060 - 54,949,142 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1454,949,060 - 54,949,142 (-)EnsemblGRCm38mm10GRCm38
MGSCv371455,567,897 - 55,567,979 (-)NCBIGRCm37MGSCv37mm9NCBIm37
Celera1452,755,093 - 52,755,175 (-)NCBICelera
Cytogenetic Map14C3NCBI
cM Map1428.0NCBI
Mir208a
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81532,395,552 - 32,395,634 (-)NCBIGRCr8
mRatBN7.21528,425,570 - 28,425,652 (-)NCBImRatBN7.2mRatBN7.2
UTH_Rnor_SHR_Utx1530,271,287 - 30,271,369 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01531,418,489 - 31,418,571 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01529,661,159 - 29,661,241 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01533,613,451 - 33,613,533 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Celera1528,003,251 - 28,003,333 (-)NCBICelera
Cytogenetic Map15p13NCBI
MIR208A
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.183,636,919 - 3,636,987 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl83,636,919 - 3,636,987 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha83,585,129 - 3,585,197 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.083,744,651 - 3,744,719 (-)NCBIROS_Cfam_1.0
UMICH_Zoey_3.183,436,201 - 3,436,269 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.083,497,685 - 3,497,753 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.083,759,684 - 3,759,752 (-)NCBIUU_Cfam_GSD_1.0


Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 14q11.2(chr14:20151149-23442195)x3 copy number gain See cases [RCV000050914] Chr14:20151149..23442195 [GRCh38]
Chr14:20619308..23911404 [GRCh37]
Chr14:19689148..22981244 [NCBI36]
Chr14:14q11.2
pathogenic
GRCh38/hg38 14q11.2-12(chr14:20151149-27723796)x1 copy number loss Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051484]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051484]|See cases [RCV000051484] Chr14:20151149..27723796 [GRCh38]
Chr14:20619308..28193002 [GRCh37]
Chr14:19689148..27262842 [NCBI36]
Chr14:14q11.2-12
pathogenic
GRCh38/hg38 14q11.2-21.2(chr14:20196945-45284802)x1 copy number loss See cases [RCV000051485] Chr14:20196945..45284802 [GRCh38]
Chr14:20665104..45754005 [GRCh37]
Chr14:19734944..44823755 [NCBI36]
Chr14:14q11.2-21.2
pathogenic
GRCh38/hg38 14q11.2(chr14:23260803-23763521)x3 copy number gain See cases [RCV000052058] Chr14:23260803..23763521 [GRCh38]
Chr14:23730012..24232730 [GRCh37]
Chr14:22799852..23302570 [NCBI36]
Chr14:14q11.2
uncertain significance
GRCh38/hg38 14q11.2-21.1(chr14:20000611-38984415)x3 copy number gain See cases [RCV000053803] Chr14:20000611..38984415 [GRCh38]
Chr14:20468770..39453619 [GRCh37]
Chr14:19538610..38523370 [NCBI36]
Chr14:14q11.2-21.1
pathogenic
GRCh38/hg38 14q11.2-21.1(chr14:20150949-39746154)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053806]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053806]|See cases [RCV000053806] Chr14:20150949..39746154 [GRCh38]
Chr14:20619108..40215358 [GRCh37]
Chr14:19688948..39285109 [NCBI36]
Chr14:14q11.2-21.1
pathogenic
GRCh38/hg38 14q11.2-32.33(chr14:20151149-106855263)x3 copy number gain See cases [RCV000135543] Chr14:20151149..106855263 [GRCh38]
Chr14:20619308..107263478 [GRCh37]
Chr14:19689148..106334523 [NCBI36]
Chr14:14q11.2-32.33
pathogenic
GRCh38/hg38 14q11.2-12(chr14:20412587-25018120)x3 copy number gain See cases [RCV000137725] Chr14:20412587..25018120 [GRCh38]
Chr14:20880746..25487326 [GRCh37]
Chr14:19950586..24557166 [NCBI36]
Chr14:14q11.2-12
likely pathogenic
GRCh38/hg38 14q11.2-32.33(chr14:20043514-106877229)x3 copy number gain See cases [RCV000143373] Chr14:20043514..106877229 [GRCh38]
Chr14:20511673..107285437 [GRCh37]
Chr14:19581513..106356482 [NCBI36]
Chr14:14q11.2-32.33
pathogenic
GRCh38/hg38 14q11.2-21.2(chr14:20022693-44093672)x3 copy number gain See cases [RCV000143186] Chr14:20022693..44093672 [GRCh38]
Chr14:20490852..44562875 [GRCh37]
Chr14:19560692..43632625 [NCBI36]
Chr14:14q11.2-21.2
pathogenic
GRCh38/hg38 14q11.2-21.3(chr14:20043513-48642042)x3 copy number gain See cases [RCV000143748] Chr14:20043513..48642042 [GRCh38]
Chr14:20511672..49111245 [GRCh37]
Chr14:19581512..48180995 [NCBI36]
Chr14:14q11.2-21.3
pathogenic
GRCh37/hg19 14q11.2-12(chr14:19100682-28730087) copy number gain not provided [RCV000767822] Chr14:19100682..28730087 [GRCh37]
Chr14:14q11.2-12
pathogenic
GRCh37/hg19 14q11.2-12(chr14:19794561-27768254)x3 copy number gain See cases [RCV000240285] Chr14:19794561..27768254 [GRCh37]
Chr14:14q11.2-12
pathogenic
GRCh37/hg19 14q11.2-22.2(chr14:23164384-54733411)x3 copy number gain See cases [RCV000447658] Chr14:23164384..54733411 [GRCh37]
Chr14:14q11.2-22.2
pathogenic
GRCh37/hg19 14q11.2-32.33(chr14:19794561-107234280)x3 copy number gain See cases [RCV000446256] Chr14:19794561..107234280 [GRCh37]
Chr14:14q11.2-32.33
pathogenic
GRCh37/hg19 14q11.2-13.1(chr14:19794561-34049214)x3 copy number gain See cases [RCV000448273] Chr14:19794561..34049214 [GRCh37]
Chr14:14q11.2-13.1
pathogenic
GRCh37/hg19 14q11.2-32.33(chr14:20511673-107285437) copy number gain See cases [RCV000512041] Chr14:20511673..107285437 [GRCh37]
Chr14:14q11.2-32.33
pathogenic
GRCh37/hg19 14q11.2(chr14:23840034-24057640)x1 copy number loss not provided [RCV000683589] Chr14:23840034..24057640 [GRCh37]
Chr14:14q11.2
uncertain significance
GRCh37/hg19 14q11.1-32.33(chr14:19000422-107289053)x3 copy number gain not provided [RCV000738412] Chr14:19000422..107289053 [GRCh37]
Chr14:14q11.1-32.33
pathogenic
GRCh37/hg19 14q11.2-32.33(chr14:19280733-107287663)x3 copy number gain not provided [RCV000738413] Chr14:19280733..107287663 [GRCh37]
Chr14:14q11.2-32.33
pathogenic
GRCh37/hg19 14q11.2-32.33(chr14:19327823-107287663)x3 copy number gain not provided [RCV000738414] Chr14:19327823..107287663 [GRCh37]
Chr14:14q11.2-32.33
pathogenic
GRCh37/hg19 14q11.2(chr14:21717093-24027220)x3 copy number gain not provided [RCV000856644] Chr14:21717093..24027220 [GRCh37]
Chr14:14q11.2
likely pathogenic
NC_000014.8:g.(?_23586696)_(23902941_?)del deletion Specific granule deficiency [RCV003107481] Chr14:23586696..23902941 [GRCh37]
Chr14:14q11.2
pathogenic
NC_000014.8:g.(?_23857696)_(23858733_?)del deletion Hypertrophic cardiomyopathy 14 [RCV003107692] Chr14:23857696..23858733 [GRCh37]
Chr14:14q11.2
uncertain significance
NC_000014.9:g.(?_23388145)_(23417328_?)del deletion Hypertrophic cardiomyopathy [RCV001032027] Chr14:23857354..23886537 [GRCh37]
Chr14:14q11.2
uncertain significance
GRCh37/hg19 14q11.2-21.2(chr14:20511672-44829030)x3 copy number gain not provided [RCV001006605] Chr14:20511672..44829030 [GRCh37]
Chr14:14q11.2-21.2
pathogenic
NC_000014.9:g.(?_23382030)_(23434247_?)dup duplication Hypertrophic cardiomyopathy [RCV001031676] Chr14:23851239..23903456 [GRCh37]
Chr14:14q11.2
uncertain significance
NC_000014.9:g.(?_23387519)_(23415842_?)dup duplication Hypertrophic cardiomyopathy 14 [RCV001345562]|Hypertrophic cardiomyopathy [RCV001031126] Chr14:23856728..23885051 [GRCh37]
Chr14:14q11.2
uncertain significance
GRCh37/hg19 14q11.2-21.1(chr14:20511672-42881888)x3 copy number gain not provided [RCV001249358] Chr14:20511672..42881888 [GRCh37]
Chr14:14q11.2-21.1
not provided
GRCh37/hg19 14q11.2-21.3(chr14:20511672-47481203) copy number gain Seizure [RCV002280625] Chr14:20511672..47481203 [GRCh37]
Chr14:14q11.2-21.3
pathogenic
NC_000014.8:g.(?_23856728)_(23885531_?)dup duplication Hypertrophic cardiomyopathy [RCV001313269] Chr14:23856728..23885531 [GRCh37]
Chr14:14q11.2
uncertain significance
NC_000014.8:g.(?_23856957)_(23886537_?)del deletion Hypertrophic cardiomyopathy [RCV001313268] Chr14:23856957..23886537 [GRCh37]
Chr14:14q11.2
uncertain significance
NC_000014.8:g.(?_23242819)_(25103366_?)dup duplication Lysinuric protein intolerance [RCV003105428]|Specific granule deficiency [RCV003105427] Chr14:23242819..25103366 [GRCh37]
Chr14:14q11.2-12
uncertain significance
NC_000014.8:g.(?_23857344)_(23886547_?)del deletion Hypertrophic cardiomyopathy [RCV003109247] Chr14:23857344..23886547 [GRCh37]
Chr14:14q11.2
uncertain significance
NC_000014.8:g.(?_23851249)_(23902941_?)dup duplication Hypertrophic cardiomyopathy [RCV003109248] Chr14:23851249..23902941 [GRCh37]
Chr14:14q11.2
uncertain significance
NC_000014.8:g.(?_23856718)_(23885061_?)dup duplication Hypertrophic cardiomyopathy [RCV001963750] Chr14:23856718..23885061 [GRCh37]
Chr14:14q11.2
uncertain significance
NC_000014.8:g.(?_23855504)_(23885061_?)del deletion Hypertrophic cardiomyopathy [RCV002049115] Chr14:23855504..23885061 [GRCh37]
Chr14:14q11.2
uncertain significance
NC_000014.8:g.(21162263_36986276)_(36987308_50713602)del deletion Brain-lung-thyroid syndrome [RCV002221171] Chr14:36986276..36987308 [GRCh37]
Chr14:14q11.2-21.3
pathogenic
GRCh37/hg19 14q11.2-23.1(chr14:20511673-61826023)x3 copy number gain not provided [RCV003485022] Chr14:20511673..61826023 [GRCh37]
Chr14:14q11.2-23.1
pathogenic
GRCh37/hg19 14q11.2(chr14:23851719-23906499)x3 copy number gain not specified [RCV003987046] Chr14:23851719..23906499 [GRCh37]
Chr14:14q11.2
uncertain significance
NC_000014.8:g.(?_23855504)_(23876432_?)dup duplication Hypertrophic cardiomyopathy 14 [RCV004578129] Chr14:23855504..23876432 [GRCh37]
Chr14:14q11.2
uncertain significance
NC_000014.8:g.(?_23854105)_(23884499_?)del deletion Hypertrophic cardiomyopathy [RCV004578056] Chr14:23854105..23884499 [GRCh37]
Chr14:14q11.2
uncertain significance
NC_000014.8:g.(?_23855117)_(23902941_?)dup duplication Hypertrophic cardiomyopathy [RCV004578057] Chr14:23855117..23902941 [GRCh37]
Chr14:14q11.2
uncertain significance
miRNA Target Status

Confirmed Targets
Gene TargetMature miRNAMethod NameResult TypeData TypeSupport TypePMID
CDKN1Ahsa-miR-208a-3pMirtarbaseexternal_infoqRT-PCR//Luciferase reporter assay//Western blotFunctional MTI20190813
MED13hsa-miR-208a-3pMirtarbaseexternal_infoLuciferase reporter assay//qRT-PCR//Western blotFunctional MTI17379774
ETS1hsa-miR-208a-3pMirtarbaseexternal_infoLuciferase reporter assay//Microarray//qRT-PCR//WeFunctional MTI20576608

Predicted Targets
Summary Value
Count of predictions:18344
Count of gene targets:6889
Count of transcripts:13062
Interacting mature miRNAs:hsa-miR-208a-3p, hsa-miR-208a-5p
Prediction methods:Microtar, Miranda, Pita, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


Expression

RNA-SEQ Expression

adipose tissue
alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
nervous system
renal system
reproductive system
respiratory system
sensory system
29 38 97 167 93 24 26 4 30 2 53 259 233 72 7 25 21 2

Sequence


Ensembl Acc Id: ENST00000362287
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl1423,388,596 - 23,388,666 (-)Ensembl
RefSeq Acc Id: NR_029595
RefSeq Status: PROVISIONAL
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh381423,388,596 - 23,388,666 (-)NCBI
GRCh371423,857,805 - 23,857,875 (-)RGD
Celera143,720,516 - 3,720,586 (-)RGD
HuRef143,974,223 - 3,974,293 (-)RGD
CHM1_11423,856,477 - 23,856,547 (-)NCBI
T2T-CHM13v2.01417,589,612 - 17,589,682 (-)NCBI
Sequence:

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:31585 AgrOrtholog
COSMIC MIR208A COSMIC
Ensembl Genes ENSG00000199157 Ensembl, ENTREZGENE
Ensembl Transcript ENST00000362287 ENTREZGENE
GTEx ENSG00000199157 GTEx
HGNC ID HGNC:31585 ENTREZGENE
Human Proteome Map MIR208A Human Proteome Map
miRBase MI0000251 ENTREZGENE
NCBI Gene 406990 ENTREZGENE
OMIM 611116 OMIM
PharmGKB PA164722586 PharmGKB
RNAcentral URS000005FEE9 RNACentral
  URS00000E5433 RNACentral
  URS0000759A9B RNACentral